Authors:
BOURRAIN S
COLLINS I
NEDUVELIL JG
ROWLEY M
LEESON PD
PATEL S
PATEL S
EMMS F
MARWOOD R
CHAPMAN KL
FLETCHER AE
SHOWELL GA
Citation: S. Bourrain et al., SUBSTITUTED PYRAZOLES AS NOVEL SELECTIVE LIGANDS FOR THE HUMAN DOPAMINE D-4 RECEPTOR, Bioorganic & medicinal chemistry, 6(10), 1998, pp. 1731-1743
Citation: Kl. Chapman et al., EVALUATION OF NONLETHAL CONTROL METHODS ON PROBLEMATIC SAMANGO MONKEYS IN THE CAPE VIDAL RECREATION RESERVE, GREATER ST. LUCIA WETLAND PARK, South African journal of wildlife research, 28(3), 1998, pp. 89-99
Authors:
PATEL S
MARWOOD R
CHAPMAN KL
PATEL S
BRISTOW LJ
KULAGOWSKI JJ
FREEDMAN SB
Citation: S. Patel et al., PROPERTIES AND POTENTIAL APPLICATIONS OF D3 AND D4 RECEPTOR ANTAGONISTS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 43-43
Citation: Kl. Chapman et Ba. Barrett, SUSCEPTIBILITY OF MALE CODLING MOTH (LEPIDOPTERA, TORTRICIDAE) TO AZINPHOSMETHYL IN MISSOURI, Journal of agricultural entomology, 14(4), 1997, pp. 441-447
Authors:
PATEL S
FREEDMAN S
CHAPMAN KL
EMMS F
FLETCHER AE
KNOWLES M
MARWOOD R
MCALLISTER G
MYERS J
PATEL S
CURTIS N
KULAGOWSKI JJ
LEESON PD
RIDGILL M
GRAHAM M
MATHESON S
RATHBONE D
WATT AP
BRISTOW LJ
RUPNIAK NMJ
BASKIN E
LYNCH JJ
RAGAN CI
Citation: S. Patel et al., BIOLOGICAL PROFILE OF L-745,870, A SELECTIVE ANTAGONIST WITH HIGH-AFFINITY FOR THE DOPAMINE-D4 RECEPTOR, The Journal of pharmacology and experimental therapeutics, 283(2), 1997, pp. 636-647
Authors:
CASTRO JL
BROUGHTON HB
RUSSELL MGN
RATHBONE D
WATT AP
BALL RG
CHAPMAN KL
PATEL S
SMITH AJ
MARSHALL GR
MATASSA VG
Citation: Jl. Castro et al., 5-(PIPERIDIN-2-YL)-1,4-BENZODIAZEPINES AND 5-(HOMOPIPERIDIN-2-YL)-1,4-BENZODIAZEPINES - HIGH-AFFINITY, BASIC LIGANDS FOR THE CHOLECYSTOKININ-B RECEPTOR, Journal of medicinal chemistry, 40(16), 1997, pp. 2491-2501
Authors:
PERRY DL
THOMPSON AC
RUSSO RE
MAO XL
CHAPMAN KL
Citation: Dl. Perry et al., CHARACTERIZATION OF QUATERNARY METAL-OXIDE FILMS BY SYNCHROTRON X-RAY-FLUORESCENCE MICROPROBE, Applied spectroscopy, 51(12), 1997, pp. 1781-1783
Authors:
SHOWELL GA
BOURRAIN S
NEDUVELIL JG
MATASSA VG
MATHESON S
PATEL S
SMITH AJ
CHAPMAN KL
MARQUISOMER D
BALL RG
Citation: Ga. Showell et al., L-743,345 - THE C5-(3-AZABICYCLO[3.2.2.]NONAN-3-YL) ANALOG OF DEVAZEPIDE, A SELECTIVE, HIGH-AFFINITY ANTAGONIST FOR THE CHOLECYSTOKININ-A RECEPTOR, Medicinal chemistry research, 6(5), 1996, pp. 312-317
Authors:
PATEL S
CHAPMAN KL
SMITH AJ
BAILEY I
FREEDMAN SB
Citation: S. Patel et al., ARE RADIOLIGAND ANTAGONIST AGONIST BINDING RATIOS IN RAT PANCREAS PREDICTIVE OF FUNCTIONAL EFFICACY OF CHOLECYSTOKININ RECEPTOR AGONISTS AND ANTAGONISTS, Regulatory peptides, 65(1), 1996, pp. 29-35
Authors:
CHAPMAN KL
BARTLEY GB
GARRRITY JA
GONNERING RS
Citation: Kl. Chapman et al., SARCOIDOSIS AND THE NASOLACRIMAL DRAINAGE SYSTEM, Investigative ophthalmology & visual science, 37(3), 1996, pp. 3949-3949
Authors:
CASTRO JL
BALL RG
BROUGHTON HB
RUSSELL MGN
RATHBONE D
WATT AP
BAKER R
CHAPMAN KL
FLETCHER AE
PATEL S
SMITH AJ
MARSHALL GR
RYECROFT W
MATASSA VG
Citation: Jl. Castro et al., CONTROLLED MODIFICATION OF ACIDITY IN CHOLECYSTOKININ B RECEPTOR ANTAGONISTS - ZEPIN-3-YL)-N'-[3-(TETRAZOL-5-YLAMINO)PHENYL]UREAS, Journal of medicinal chemistry, 39(4), 1996, pp. 842-849
Authors:
MILLS SG
MACCOSS M
CASCIERI MA
SADOWSKI S
PATEL S
CHAPMAN KL
HUTSON PH
Citation: Sg. Mills et al., 1,2,4-TRIACYLPIPERIDINE SUBSTANCE-P ANTAGONISTS - SEPARATION OF AFFINITIES FOR THE NK-1 RECEPTOR AND THE L-TYPE CALCIUM-CHANNEL, Bioorganic & medicinal chemistry letters, 5(6), 1995, pp. 599-604
Authors:
PATEL S
PATEL S
MARWOOD R
CHAPMAN KL
EMMS F
FREEDMAN SB
Citation: S. Patel et al., IN-VITRO CHARACTERIZATION OF [H-3] PD12897 AS A SELECTIVE RADIOLIGANDFOR THE DOPAMINE D3 RECEPTOR, British Journal of Pharmacology, 114, 1995, pp. 347-347
Authors:
PATEL S
SMITH AJ
CHAPMAN KL
FLETCHER AE
KEMP JA
MARSHALL GR
HARGREAVES RJ
RYECROFT W
IVERSEN LL
IVERSEN SD
BAKER R
SHOWELL GA
BOURRAIN S
NEDUVELIL JG
MATASSA VG
FREEDMAN SB
Citation: S. Patel et al., BIOLOGICAL PROPERTIES OF THE BENZODIAZEPINE AMIDINE DERIVATIVE L-740,093, A CHOLECYSTOKININ-B GASTRIN RECEPTOR ANTAGONIST WITH HIGH-AFFINITY IN-VITRO AND HIGH POTENCY IN-VIVO, Molecular pharmacology, 46(5), 1994, pp. 943-948
Authors:
BOCK MG
DIPARDO RM
MELLIN EC
NEWTON RC
VEBER DF
FREEDMAN SB
SMITH AJ
PATEL S
KEMP JA
MARSHALL GR
FLETCHER AE
CHAPMAN KL
ANDERSON PS
FREIDINGER RM
Citation: Mg. Bock et al., 2ND-GENERATION BENZODIAZEPINE CCK-B ANTAGONISTS - DEVELOPMENT OF SUBNANOMOLAR ANALOGS WITH SELECTIVITY AND WATER SOLUBILITY, Journal of medicinal chemistry, 37(6), 1994, pp. 722-724
Authors:
PATEL S
CHAPMAN KL
HEALD A
SMITH AJ
FREEDMAN SB
Citation: S. Patel et al., MEASUREMENT OF CENTRAL-NERVOUS-SYSTEM ACTIVITY OF SYSTEMICALLY ADMINISTERED CCKB RECEPTOR ANTAGONISTS BY EX-VIVO BINDING, European journal of pharmacology, 253(3), 1994, pp. 237-244
Authors:
VANDEMARK DR
HARDINJONES MA
OGARA MM
LOGEMANN JA
CHAPMAN KL
Citation: Dr. Vandemark et al., IDENTIFICATION OF CHILDREN WITH AND WITHOUT CLEFT-PALATE FROM TAPE-RECORDED SAMPLES OF EARLY VOCALIZATIONS AND SPEECH, The Cleft palate-craniofacial journal, 30(6), 1993, pp. 557-563